Summary
Transfusion of blood is associated with high costs in the anaesthesia department. Immunological testing and/or cross-matching is routinely done before many operations entailing only a small risk of major haemorrhage. The introduction of artificial oxygen substitutes would save not only the cost of the erythrocytes but also of the extensive blood testing. In operations with an expected large blood loss, competition with donated blood will probably be focused largely on the potential prevention of adverse effects and infection. In the intensive care unit, a beneficial influence on blood rheology is more important than during surgery, and it must be possible to evaluate oxygen delivery after administration of the artificial oxygen substitute. For trauma outside hospital, artificial oxygen substitutes compete with fluid resuscitation as donated blood is rarely an option. Surprisingly, it is currently unclear where and when fluid resuscitation should be provided in the prehospital setting. Long transport times and head trauma are currently the most apparent indications. Artificial oxygen substitutes should be available at short notice, i.e., not requiring thawing, in order to be successful products. Here, volume expansion is a desired property along with improvement in oxygen-carrying capacity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ekengren J, Hahn RG (1993) Blood loss during transurethral resection of the prostate as measured with the HemoCue photometer. Scand J Urol Nephrol 27:501–507
Leung JM, Weiskopf RB, Feiner J, et al (2000) Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology 93:1004–1010
Stehling L, Doherty DC, Faust RJ, et al (1996) Practice guidelines for blood component therapy. A report of the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 84:732–747
Bourke DL, Smith TC (1974) Estimating allowable blood loss. Anesthesiology 41:609–612
Hahn RG (1989) Estimating allowable blood loss with correction for variations in blood volume. Acta Anaesthesiol Scand 33:508–512
Hahn RG (1987) A haemoglobin dilution method (HDM) for estimation of blood volume variations during transurethral prostatic surgery. Acta Anaesthesiol Scand 31:572–578
Kristiansson M, Soop M, Saraste L, et al (1995) Cytokine and coagulation characteristics of retrieved blood after arthroplasty. Int Care Med 21:989–995
Hébert PC, Wells G, Tweeddale M, et al (1997) Does transfusion practice affect mortality in critically ill patients? Transfusion requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med 155:1618–1623
Hébert PC, Wells G, Blajchman MA, et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials. N Engl J Med 340:409–417
Shackford SR, Mackersie RC, Holbrook TL, et al (1993) The epidemiology of traumatic death. A population-based analysis. Arch Surg 128:571–575
Stern SA, Dronen SC, Birrer P, Wang X (1995) Effect of blood pressure on hemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury. Ann Emerg Med 22:155–163
Riddez L, Johnsson L, Hahn RG (1998) Central and regional hemodynamics during fluid therapy after uncontrolled intra-abdominal bleeding. J Trauma 44:433–439
Dutton RP, Mackenzie CF, Scalea TM (2002) Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 52:1141–1146
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Tokyo
About this paper
Cite this paper
Hahn, R.G. (2005). Clinical Needs for Artificial Oxygen Carriers in Anaesthesia. In: Kobayashi, K., Tsuchida, E., Horinouchi, H. (eds) Artificial Oxygen Carrier. Keio University International Symposia for Life Sciences and Medicine, vol 12. Springer, Tokyo. https://doi.org/10.1007/4-431-26651-8_21
Download citation
DOI: https://doi.org/10.1007/4-431-26651-8_21
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-22074-9
Online ISBN: 978-4-431-26651-8
eBook Packages: MedicineMedicine (R0)